1 |
Fock KM (2014). Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther, 40, 250-60.
DOI
|
2 |
Imani-Saber Z, Ghafouri-Fard S (2014). Promyelocytic leukemia gene functions and roles in tumorigenesis. Asian Pac J Cancer Prev, 15, 8021-8.
|
3 |
Imani-Saber Z, Yousefi-Razin E, Javaheri M, et al (2015). PML gene mutations do not contribute in gastric adenocarcinoma. Asian Pac J Cancer Prev, [Epub ahead of print].
|
4 |
Kim HJ, Song DE, Lim SY, et al (2011). Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes. PLoS One, 6, 26264.
DOI
|
5 |
Lee HE, Jee CD, Kim MA, et al (2007). Loss of promyelocytic leukemia protein in human gastric cancers. Cancer Lett, 247, 103-9.
DOI
|
6 |
Sivachandran N, Cao JY, Frappier L (2010). Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol, 84, 11113-23.
DOI
|
7 |
Sivachandran N, Dawson CW, Young LS, et al (2012). Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol, 86, 60-8.
DOI
|
8 |
Wei J, Nagy TA, Vilgelm A, et al (2010). Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterol, 139, 1333-43.
DOI
|